Results 81 to 90 of about 2,055,082 (206)
Gastric bypass reversal in patients with short bowel syndrome
Background: 5–10 % patients developing short bowel syndrome (SBS) have undergone a previous gastric bypass (GBP) for morbid obesity. The benefits of restoring gastric anatomy in these patients is assumed but remains unclear.
Jon S. Thompson +7 more
doaj +1 more source
Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim +7 more
wiley +1 more source
Background: Massive bowel resection (MBR), defined as residual small bowel
Clarelle L. Gonsalves +6 more
doaj +1 more source
The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad +2 more
wiley +1 more source
Background: Patients with short bowel syndrome (SBS) have a loss of absorptive bowel surface area and are at risk for dehydration. Oral rehydration solutions (ORS) promote intestinal fluid absorption and may be used to maintain adequate hydration ...
Juliana Kennedy +4 more
doaj +1 more source
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault +12 more
wiley +1 more source
Assessment and management of patients with intestinal failure: a multidisciplinary approach
Jennie T Grainger,1 Yasuko Maeda,1,2 Suzanne C Donnelly,1 Carolynne J Vaizey1,2 1The Lennard Jones Intestinal Failure Unit, St. Mark’s Hospital, Harrow, UK; 2Faculty of Medicine, Imperial College London, London, UK Abstract: Intestinal failure (IF)
Maeda Y +3 more
core
MMIHS is a rare congenital disease. It is characterized by distended urinary bladder, small colon and intestinal hypoperistalsis, or aperistalsis with normal morphology. There is no specific treatment for MMIHS, and most patients have to be maintained by
曾勝弘 +1 more
core +1 more source
Interactions of intestinal epithelial cells with bacterial extracellular products [PDF]
The enteric microflora represents one of the densest microbial populations in the biological world; as a consequence, the intestinal immune system is constantly exposed to high concentrations of antigenic materials. One of the major frontline defences in
Patten, Daniel
core +3 more sources
Background: Neonatal intestinal failure related to double enterostomies is rare and associated with high morbidity and mortality. Chyme reinfusion therapy (CRT) remediates high outputs and improves nutrition and electrolyte balance of neonates.
Taylor Harrington, Emma Ludlow
doaj +1 more source

